Aliento Life Sciences Private Limited
About Aliento Life Sciences Private Limited
Data last updated:
Aliento Life Sciences Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 14 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2013PTC057718. Its GSTIN is 09AALCA7408A1ZV (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Varisha and Salman Ahmad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 425/1 Chatta Doly Wala Khair Nagar, Meerut, Uttar Pradesh, India – 250002.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.47 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net loss of ₹1.68 Lakh (net margin -26%) and EBITDA of -₹1.68 Lakh (EBITDA margin -26%). Revenue has declined at a compounded annual rate (CAGR) of 788% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address425/1 Chatta Doly Wala Khair Nagar, Meerut, Uttar Pradesh, India – 250002
- IndustryHealthcare, Other Hospital And Medical Care Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Aliento Life Sciences Private Limited
FY 2025 filings availableAliento Life Sciences Private Limited reported revenue of ₹6.47 Lakh (down 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 24% fall in the latest year. EBITDA fell 141% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | -₹1.68 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹1.68 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -26% | |
| Net Profit Margin | -26% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aliento Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Aliento Life Sciences Private Limited
Aliento Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varisha | Director | 29 Sep 2018 | 8 Years 0 Months | Current |
| Salman Ahmad | Director | 14 Jun 2013 | 13 Years 4 Months | Current |
Auditor Details
Aliento Life Sciences Private Limited is audited by DHRUV ARORA & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DHRUV ARORA & ASSOCIATES | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Aliento Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Aliento Life Sciences.
: available in the company report
Recent Activity
Aliento Life Sciences Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Deepak Sharma ceased to be Director on 18 Apr 2019.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Aliento Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AALCA7408A1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Aliento Life Sciences is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 14 June 2013 (13+ years old) and is registered under CIN U24233UP2013PTC057718.
Aliento Life Sciences has 2 current directors:
- Varisha - Director
- Salman Ahmad - Director
The latest financial statements of Aliento Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aliento Life Sciences is 09AALCA7408A1ZV, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aliento Life Sciences is U24233UP2013PTC057718. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aliento Life Sciences was incorporated on 14 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Deepak Sharma ceased to be Director on 18 Apr 2019. Izhar Ul Haq ceased to be Director on 18 Apr 2019. Varisha was appointed as Director on 29 Sep 2018. Aliento Life Sciences has 4 board changes on record in total.
The registered office of Aliento Life Sciences is at 4251 Chatta Doly Wala Khair Nagar, Meerut, Uttar Pradesh, India – 250002.
Aliento Life Sciences operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Aliento Life Sciences is compliant as of 30 September 2026. The company is actively filing with the Registrar of Companies.